Krzysztof Dyrbuś

MD, PhD, Habilitated doctor of Medicine

III Dept. and Clinic of Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland

Education

Degree #1: PhD	Year of graduation: 2004
Name of university/institute: Śląska Akademia Medyczna, Katowice, Poland
Degree #2: Habilitated doctor of Medicine	Year of graduation: 2022
Name of university/institute: Śląski Uniwersytet Medyczny (Medical University of Silesia), Katowice, Poland

Postgraduate education/specialization/training

Qualification #1: 1st degree of specialization in the field of internal medicine, dates of attendance: 1994-1997

Qualification #2: 2nd degree of specialization in the field of internal medicine (board of internal medicine), dates of attendance:1998-2000

Qualification #3: Board of cardiology, dates of attendance: 2003-2005

Dyrbuś Krzysztof, Osadnik Tadeusz, Desperak Piotr, Desperak Aneta, Gąsior Mariusz, Banach
Maciej: Evaluation of dyslipidaemia and the impact of hypolipidemic therapy on prognosis in high and very high-risk patients through the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) Registry. Pharmacol.Res. 2018: Vol.132, p.204-210 p-ISSN: 1043-6618

Dyrbuś Krzysztof, Gąsior Mariusz, Desperak Piotr, Nowak Jolanta, Osadnik Tadeusz, Banach Maciej:
Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes – Data from the TERCET registry with 19,287 patients. Pharmacol.Res. 2019: Vol.139, p.460-466 p-ISSN: 1043-6618

Dyrbuś Krzysztof, Gąsior Mariusz, Desperak Piotr, Osadnik Tadeusz, Nowak Jolanta, Banach Maciej: The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
Atherosclerosis: 2019: Vol.288, p.33-41 p-ISSN: 0021-9150 e-ISSN: 1879-1484

Dyrbuś Krzysztof, Gąsior Mariusz, Penson Pete, Ray Kausik K, Banach Maciej. Inclisiran-New hope in the management of lipid disorders?. J Clin Lipidol. 2020;14(1):16-27. doi:10.1016/j.jacl.2019.11.001

Krzysztof Dyrbuś, Mariusz Gąsior, Dariusz Dudek, Adam Witkowski, Maciej Banach: „Leczeniezaburzeń lipidowych u chorych z przewlekłym zespołem wieńcowym i z ostrym zespołem wieńcowym.
Opinia ekspertów Polskiego Towarzystwa Kardiologicznego i Polskiego Towarzystwa Lipidologicznego” Zeszyty Edukacyjne. Kardiologia Polska 2020/5: 98-132

Maciej Banach, Peter Penson, Michal Vrablik, Matjaz Bunc, Krzysztof Dyrbuś, Jan Fedacko, Dan Gaita, Marek Gierlotka, Zoltan Jarai, Stefania Lucia Magda, Eduard Margetic, Roman Margoczy, Azra Durak-Nalbantic, Petr Ostadal, Daniel Pella, Matias Trbusic, Cristian Alexandru Udroiu, Charalambos Vlachopoulos, Dusko Vulic, Zlatko Fras, Dariusz Dudek, Željko Reiner 21, ACS EuroPath Central &amp; South European Countries Project: Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP). Pharmacol Res. 2021;166:105499. doi:10.1016/j.phrs.2021.105499

Świerad M, Dyrbuś K, Szkodziński J, Zembala MO, Kalarus Z, Gąsior M. Telehealth visits in a tertiary cardiovascular center as a response of the healthcare system to the severe acute respiratory syndrome coronavirus 2 pandemic in Poland. Pol Arch Intern Med. 2020;130(7-8):700-703. doi:10.20452/pamw.15370

Dyrbuś K, Gąsior M, Desperak P, et al. Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry. Atherosclerosis. 2021;333:16-23. doi:10.1016/j.atherosclerosis.2021.08.024

Dyrbuś K, Gąsior M, Penson PE, Banach M. Extreme cardiovascular risk-do we need a new risk category? [published online ahead of print, 2021 Nov 18]. Eur Heart J. 2021;ehab771. doi:10.1093/eurheartj/ehab771

Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, Piotr Dobrowolski, Dariusz Dudek, Krzysztof Dyrbuś, Mariusz Gąsior, Piotr Jankowski, Jacek Jóźwiak, Longina Kłosiewicz-Latoszek, Irina Kowalska, Maciej Małecki, Aleksander Prejbisz, Michał Rakowski, Jacek Rysz, Bogdan Solnica, Dariusz Sitkiewicz, Grażyna Sygitowicz, Grażyna Sypniewska, Tomasz Tomasik, Adam Windak, Dorota Zozulińska-Ziółkiewicz, Barbara Cybulska: PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on the diagnosis and therapy of lipid disorders in Poland. Arch Med Sci 2021; 17(6): doi: 10.5114/aoms/141941
Dyrbuś K, Trzeciak P, Piegza J, et al. Practical aspects of endomyocardial left ventricular biopsy – own experience. Postepy Kardiol Interwencyjnej. 2021;17(4):398-402. doi:10.5114/aic.2021.109833

Świerad M, Świerad I, Szydło R, Honisz G, Gąsior M, Kalarus Z, Dyrbuś K. Assessment of the Level of Anxiety for COVID-19 Vaccinations. Vaccines (Basel). 2022 Jun 9;10(6):915. doi: 10.3390/vaccines10060915. PMID: 35746523; PMCID: PMC9227172.
Lewek J, Niedziela J, Desperak P, Dyrbuś K, Osadnik T, Jankowski P, Witkowski A, Bielecka-Dąbrowa A, Dudek D, Gierlotka M, Gąsior M, Banach M. Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL-ACS Data. J Am Heart Assoc. 2023 Sep 19;12(18):e030414. doi: 10.1161/JAHA.123.030414. Epub 2023 Sep 6. PMID: 37671618; PMCID: PMC10547305.

Leader of the project: “Lipidogram for the First Grade,” the first campaign in Poland to measure cholesterol in 7-year-olds starting primary school in Zabrze
Co-leader of the project: „Zabrze-Lip(a)R Registry”, the largest (so far) register of lipoprotein(a) in Poland gathering in very-high-risk patients.
Program for treating patients with FH and after MI with PCSK9 inhibitors.
Extreme cardiovascular risk
Project „0 Calcium in coronary vessels” (in short, a patient with CS 1 is an entirely different patient than one with CS 0 – with a completely different risk and prognosis).